Core Scientific vs Dave
CORZ and DAVE side by side, both in finance services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CORZ and DAVE compare
Core Scientific is the larger company, worth 1.3 times as much as Dave ($4.7B against $3.6B).
Core Scientific grew revenue faster over the last twelve months (77.2% versus 40.6% for Dave).
Dave keeps more of each dollar of sales as profit, with a net margin of 28.1% compared with −18.3% at Core Scientific.
Dave scores higher on the StockData Score (8 against 4 for Core Scientific), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CORZ | DAVE |
|---|---|---|
| Size and price | ||
| Market cap | $4.7B | $3.6B |
| Share price | $14.57 | $281.96 |
| Change, 1 year | −24.5% | 14.2% |
| Change, 5 years | – | −12.0% |
| Beta (5Y) | – | 2.12 |
| Employees | 325 | 280 |
| StockData Score | ||
| Total score | 4 | 8 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 | 2 |
| Performance score | 2 | 3 (better) |
| Health score | 0 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 22.8× |
| P/S | 7.9× | 5.2× (better) |
| P/B | – | 13.1× |
| EV/EBITDA | – | 13.8× |
| P/FCF | – | 11.1× |
| FCF yield | −28.2% | 9.0% (better) |
| Fair value | $5.33 | $241.64 |
| Margin of safety | −173% | −16.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 77.2% (better) | 40.6% |
| Revenue growth, 5Y average | 39.5% | – |
| Net income growth (TTM) | – | 32.5% |
| EPS growth (TTM) | – | 22.7% |
| Profitability | ||
| Gross margin | 41.2% | – |
| Operating margin | −73.3% | – |
| Net margin | −18.3% | 28.1% (better) |
| FCF margin | −223% | 47.0% (better) |
| Return on equity | – | 68.8% |
| Return on invested capital | −39.0% | – |
| Financial health | ||
| Current ratio | 0.67 | 4.22 (better) |
| Altman Z-score | −0.93 | 8.48 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 6.2% |
| Shareholder yield | 0.00% | 6.2% (better) |
| Ownership | ||
| Held by institutions | 136% | – |
| Held by insiders | 11.7% | 15.2% |
| Insider net buying, 12 months | −$6.1M (better) | −$31.5M |
| Superinvestors holding | 3 | – |
Go deeper
- CORZ stock overview
- CORZ income statement
- CORZ valuation and score
- DAVE stock overview
- DAVE income statement
- DAVE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.